From Solve Seed Funding to $3M NIH Grant for ME/CFS Research
Solve Ramsay Research Grant winner Dr. Lubov Nathanson and her team at Nova Southeastern University have been awarded a $3 million grant from the National Institutes of Health (NIH) to lead a […]
New Catalyst Award Funding From Solve M.E. Advances Innovative ME/CFS and Long Covid Studies Toward Treatments
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning research studies aimed at accelerating progress toward diagnostics and treatments for ME/CFS and Long Covid. […]
Why Public Comments Matter: How Solve Protects Patients Before Policies and Trials are Set in Stone
When an organization, like a government agency, company, or nonprofit, considers a big change or launches a new initiative, it may ask for feedback from the public during a public […]
Solve Science Spotlight: Systematic Underfunding of Long Covid, ME/CFS, and Other Debilitating Diseases That Disproportionately Affect Women
Dr. Karen Bonuck is professor of family and social medicine at Albert Einstein College of Medicine. Her research uses diverse methods to understand the burden of different disabilities among children […]
Advocacy Update: Three Crucial ME/CFS Federal Budget Wins
Hi all, I wanted to circle back with a quick update: the federal funding bills covering Labor, Health and Human Services and the Department of Defense are now final. This […]
Solve, Partners Recommend Subgroup Analysis for ME/CFS, POTS, and MCAS in NIH RECOVER TLC Trials
Today, Solve joined #MEAction, Bateman Horne Center, Simmaron Research, Open Medicine Foundation, and other organizations in a sign-on letter urging the National Institutes of Health (NIH) leadership to include subgroup […]
Solve CEO Emily Taylor Co-Authors RECOVER Study On Risk of Developing ME/CFS After COVID
Solve CEO Emily Taylor and co-authors from esteemed organizations including the Bateman Horne Center; New York University; the Patient Led Research Collaboration on COVID-19; the University of California, San Francisco; […]
Solve CEO Emily Taylor Calls for More Research Funding, New NIH Office in “Open Access Government”
Solve President and CEO Emily Taylor recently penned an op-ed piece for Open Access Government calling for more funding and multidisciplinary collaboration for research of ME/CFS, Long Covid, and other […]
ME/CFS Research Roadmap Approved by the NIH NANDS Council
In an effort to move the ME/CFS field toward translational studies and clinical trials, the National Institute of Neurological Disorders and Stroke (NINDS) ME/CFS Research Roadmap was approved this week […]
Solve Releases New White Paper: A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH
Complementing our Advocacy Week 2024 efforts, Solve has co-authored a new white paper, “A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH.” Co-written by Solve President and CEO […]
Solve VP of Advocacy Emily Taylor talks to STAT About the Push For a New Coordinating Mechanism at NIH for Infection-Associated Chronic Conditions
On March 15, Long Covid Awareness Day, Solve’s VP of Advocacy and Engagement Emily Taylor was quoted by STAT in its coverage of the push for a new office at […]
Solve Announces Congressional Asks for Advocacy Week 2024
Advocacy Week is a nationwide advocacy effort to connect people with ME/CFS, Long Covid, POTS and other dysautonomias, Chronic Lyme, and other infection-associated chronic conditions and illnesses; scientists; clinicians and […]